Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis
ADR ID BADD_A02019
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.004      Hepatitis
Description INFLAMMATION of the LIVER. [MeSH]
MedDRA Code 10019717
MeSH ID D006505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatitis | Hepatitis in other infectious diseases classified elsewhere | Hepatitis nonicteric | Hepatitis nonspecific | Hepatitis NOS | Hepatitis reactive non-specific | Hepatitis symptom | Hepatitis, unspecified | Nonspecific hepatitis | Hepatitis aggravated | Hepatitis non-icteric | Syncytial giant cell hepatitis | Hepatitis flare | Liver inflammation | Icteric hepatitis | Hepatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01237Labetalol hydrochloride--
BADD_D01238Lacosamide0.002925%
BADD_D01241Lamisil--
BADD_D01242Lamivudine0.004048%
BADD_D01243Lamotrigine0.000800%
BADD_D01245Lansoprazole0.000646%
BADD_D01248Lapatinib0.000112%
BADD_D01250Lasofoxifene--
BADD_D01252Leflunomide0.003428%
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib0.000336%
BADD_D01255Lercanidipine--
BADD_D01257Letrozole0.000395%
BADD_D01260Leuprolide acetate--
BADD_D01265Levetiracetam0.001312%
BADD_D01272Levocetirizine--
BADD_D01273Levocetirizine dihydrochloride--
BADD_D01275Levofloxacin0.000253%
BADD_D01295Linezolid0.004116%
BADD_D01298Liraglutide--
BADD_D01299Lisdexamfetamine dimesylate--
BADD_D01300Lisinopril--
BADD_D01304Lithium cation0.000192%
BADD_D01309Lomefloxacin--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01318Lorazepam0.000046%
BADD_D01322Losartan0.000025%
BADD_D01323Losartan potassium--
BADD_D01325Lovastatin--
BADD_D01326Loxapine--
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 21 Pages
ADReCS-Target
ADR Term Drug Name Target